NRINX Mutual Fund

NRINX Mutual Fund

NAV$29.08
See how much of NRINX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$108M
Expense Ratio
0.86%
Dividend Yield (Current)
0.08%
Holdings
110
Inception Date
Jan 18, 2019
Fund Family
Neuberger Berman
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+16.76%
1 Year+21.89%
3 Year+21.44%
5 Year+7.09%
10 Year+12.16%

Asset Allocation

Stocks: 100.00%
See how much of NRINX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
VECOVeeco Instruments Inc3.61%
VSATViasat Inc3.47%
HAEHaemonetics Corp2.75%
KBRKbr Inc2.57%
VRNSVaronis Systems Inc2.52%
Top 10 Concentration: 25.32%Report Date: Sep 30, 2026
Download all 110 holdings for NRINX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.08%
Frequency
Annually
Latest Distribution
$1.48
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

NRINX Mutual Fund Overview

NRINX Mutual Fund (Neuberger Berman Intrinsic Value Fund Class R6) is managed by Neuberger Berman with $107.7M in net assets. NRINX expense ratio is 0.86%, holding 110 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2019-01-18.

NRINX performance shows a YTD return of 16.76%. The 1-year return is 21.89% and the 5-year return is 7.09%. NRINX dividend yield stands at 0.08%, paid annually.

NRINX top holdings include Veeco Instruments Inc (3.6%), Viasat Inc (3.5%), Haemonetics Corp (2.8%), Kbr Inc (2.6%), Varonis Systems Inc (2.5%). Go to all NRINX holdings, NRINX sectors, or NRINX dividends.

NRINX can be compared against other funds. Use NRINX overlap to find shared positions, or NRINX vs another fund for a side-by-side view. NRINX alternatives are available via the screener, along with tax-loss harvesting opportunities.